Journal
MUCOSAL IMMUNOLOGY
Volume 11, Issue 5, Pages 1408-1419Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/s41385-018-0049-9
Keywords
-
Categories
Funding
- European Respiratory Society
- Wellcome Trust [TSCH-088365/z/09/z, 104553/Z/14/Z, PK-WT109965MA]
- Academy of Medical Sciences
- MRC
- NIHR Oxford Biomedical Research Centre Programme
- NIHR Academic Clinical Fellowship
- NIHR Senior Fellowship
- Oxford Martin School
- British Medical Association (The James Trust 2011)
- MRC [G0701693, MC_UU_00008/5, MC_U137881017, MC_UU_12010/5, G116/150] Funding Source: UKRI
Ask authors/readers for more resources
Human type-2 CD8(+) T cells are a cell population with potentially important roles in allergic disease. We investigated this in the context of severe asthma with persistent airway eosinophilia-a phenotype associated with high exacerbation risk and responsiveness to type-2 cytokine-targeted therapies. In two independent cohorts we show that, in contrast to Th2 cells, type-2 cytokine-secreting CD8(+)CRTH2(+) (Tc2) cells are enriched in blood and airways in severe eosinophilic asthma. Concentrations of prostaglandin D-2 (PGD2) and cysteinyl leukotriene E-4 (LTE4) are also increased in the airways of the same group of patients. In vitro PGD(2) and LTE4 function synergistically to trigger Tc2 cell recruitment and activation in a TCR-independent manner. These lipids regulate diverse genes in Tc2 cells inducing type-2 cytokines and many other pro-inflammatory cytokines and chemokines, which could contribute to eosinophilia. These findings are consistent with an important innate-like role for human Tc2 cells in severe eosinophilic asthma and suggest a potential target for therapeutic intervention in this and other diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available